Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
DOSING REGIMEN OF ANTI-ALPHA4BETA7-ANTIBODY

No-Receipt date 2025-01142 - 01/04/2025
No-Filing date 20250400684 - 01/04/2025
No-Granting date 3117928 - 15/04/2025
No-EPO application date 18150968.8 - 02/05/2012
No-EPO granting date 3329965 - 19/03/2025
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 4/2025 - 14/05/2025
Expiration date 03/05/2032
Kind of title Validation of European Patent
Legal status VALID
Priorities US201161481533 P02/05/2011/US
US201161550545 P24/10/2011/US
US201261585859 P12/01/2012/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07K 16/28
A61P 1/00
A61K 9/19
A61K 9/00
A61K 47/26
A61K 47/18
A61K 39/395
A61K 39/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1738631 MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREETCAMBRIDGE, MA 02139 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4562865 DILUZIO, WILLOW
4562866 TRUONG, NOBEL T.
4562867 VARGA, CSANAD M.
4562868 PALANIAPPAN, VAITHIANATHAN
4562869 BROWN, JASON
4562870 FOX, IRVING H.
4562871 SCHOLZ, CATHERINE

Representatives
CodeFirstnameSurnameAddressTownZip
2011VALI-VASILIKISAKELLARIDIADRIANOY 70ATHINA (ATTIKIS)10556

Contact
CodeFirstnameSurnameAddressTownZipCountry
5848VALI-VASILIKISAKELLARIDIADRIANOY 70ATHINA (ATTIKIS)10556 GREECE

Owners History

Title Instruments

Payments history 14 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015